Jasper Therapeutics CEO Ronald Martell's 2023 pay falls 40% to $3.4M

Jasper Therapeutics reports 2023 executive compensation

By ExecPay News

Published: April 22, 2024

Jasper Therapeutics reported fiscal year 2023 executive compensation information on April 22, 2024.
In 2023, four executives at Jasper Therapeutics received on average a compensation package of $1.5M, a 25% decrease compared to previous year.
Average pay of disclosed executives at Jasper Therapeutics
Ronald Martell, Chief Executive Officer, received $3.4M in total, which decreased by 40% compared to 2022. 70% of Martell's compensation, or $2.4M, was in option awards. Martell also received $313K in non-equity incentive plan and $695K in salary.
Jeet Mahal, Chief Operating Officer, received a compensation package of $1.2M, which increased by 7% compared to previous year. 45% of the compensation package, or $536K, was in option awards.
Edwin Tucker, Chief Medical Officer, earned $978K in 2023.
Herb Cross, Chief Financial Officer, received $643K in 2023.

Related executives

Ronald Martell

Jasper Therapeutics

Chief Executive Officer

Herb Cross

Jasper Therapeutics

Chief Financial Officer

Jeet Mahal

Jasper Therapeutics

Chief Operating Officer

Edwin Tucker

Jasper Therapeutics

Chief Medical Officer

You may also like

Source: SEC filing on April 22, 2024.